MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.48
-0.28 (-1.67%)
Nov 22, 2024, 4:00 PM EST - Market closed
MediWound Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 20.14 | 18.69 | 26.5 | 23.76 | 21.76 | 31.79 | Upgrade
|
| Revenue Growth (YoY) | -22.51% | -29.48% | 11.50% | 9.19% | -31.54% | 834.70% | Upgrade
|
| Cost of Revenue | 17.47 | 15.11 | 13.33 | 14.99 | 14.22 | 11.85 | Upgrade
|
| Gross Profit | 2.67 | 3.58 | 13.17 | 8.77 | 7.55 | 19.94 | Upgrade
|
| Selling, General & Admin | 11.31 | 11.61 | 10.65 | 9.74 | 8.69 | 9.31 | Upgrade
|
| Research & Development | 6.71 | 7.47 | 9.98 | 10.26 | 7.7 | 4.97 | Upgrade
|
| Operating Expenses | 18.02 | 19.08 | 20.62 | 19.99 | 16.39 | 14.28 | Upgrade
|
| Operating Income | -15.35 | -15.5 | -7.46 | -11.22 | -8.84 | 5.67 | Upgrade
|
| Interest Expense | -11.34 | -0.27 | -0.1 | -0.12 | -0.83 | -0.93 | Upgrade
|
| Interest & Investment Income | - | 2.34 | 0.27 | 0.01 | 0.3 | 0.43 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.65 | -0.65 | 0.06 | -0.51 | 0.11 | 0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -0.07 | -11 | -0.19 | -0.45 | -0.37 | Upgrade
|
| EBT Excluding Unusual Items | -27.41 | -14.16 | -18.23 | -12.03 | -9.71 | 4.93 | Upgrade
|
| Other Unusual Items | 7.63 | 7.63 | -1.29 | -1.49 | 0.43 | -2.86 | Upgrade
|
| Pretax Income | -19.78 | -6.53 | -19.52 | -13.52 | -9.28 | 2.07 | Upgrade
|
| Income Tax Expense | 0.19 | 0.19 | 0.08 | 0.03 | - | - | Upgrade
|
| Earnings From Continuing Operations | -19.97 | -6.72 | -19.6 | -13.55 | -9.28 | 2.07 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 0.08 | 2.89 | Upgrade
|
| Net Income | -19.97 | -6.72 | -19.6 | -13.55 | -9.2 | 4.96 | Upgrade
|
| Net Income to Common | -19.97 | -6.72 | -19.6 | -13.55 | -9.2 | 4.96 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 5 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 5 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 28.90% | 80.73% | 28.13% | 0.24% | 0.00% | 0.24% | Upgrade
|
| EPS (Basic) | -2.16 | -0.75 | -3.93 | -3.48 | -2.37 | 1.28 | Upgrade
|
| EPS (Diluted) | -2.16 | -0.75 | -3.93 | -3.48 | -2.37 | 1.28 | Upgrade
|
| Free Cash Flow | -22.27 | -16.93 | -12.44 | -9.41 | -7.82 | 7.5 | Upgrade
|
| Free Cash Flow Per Share | -2.41 | -1.88 | -2.49 | -2.42 | -2.01 | 1.93 | Upgrade
|
| Gross Margin | 13.25% | 19.15% | 49.69% | 36.91% | 34.67% | 62.73% | Upgrade
|
| Operating Margin | -76.20% | -82.96% | -28.14% | -47.22% | -40.62% | 17.82% | Upgrade
|
| Profit Margin | -99.17% | -35.94% | -73.97% | -57.03% | -42.26% | 15.59% | Upgrade
|
| Free Cash Flow Margin | -110.55% | -90.60% | -46.95% | -39.58% | -35.92% | 23.58% | Upgrade
|
| EBITDA | -14.5 | -14.76 | -6.72 | -9.98 | -7.75 | 6.81 | Upgrade
|
| EBITDA Margin | -72.01% | -79.01% | -25.37% | -42.01% | -35.61% | 21.43% | Upgrade
|
| D&A For EBITDA | 0.85 | 0.74 | 0.73 | 1.24 | 1.09 | 1.15 | Upgrade
|
| EBIT | -15.35 | -15.5 | -7.46 | -11.22 | -8.84 | 5.67 | Upgrade
|
| EBIT Margin | -76.20% | -82.96% | -28.14% | -47.22% | -40.62% | 17.82% | Upgrade
|
| Revenue as Reported | 20.14 | 18.69 | 26.5 | 23.76 | 21.76 | 31.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.